Dogwood Therapeutics, Inc.

NASDAQ (USD): Dogwood Therapeutics, Inc. (DWTX)

Last Price

13.66

Today's Change

+10.86 (387.92%)

Day's Change

2.72 - 29.28

Trading Volume

100,725,034

Overview

Market Cap

18 Million

Shares Outstanding

1 Million

Avg Volume

464,428

Avg Price (50 Days)

2.64

Avg Price (200 Days)

5.34

PE Ratio

-2.18

EPS

-6.32

Earnings Announcement

26-Feb-2025

Previous Close

2.80

Open

2.72

Day's Range

2.72 - 29.28

Year Range

1.62 - 29.28

Trading Volume

100,749,371

Price Change Highlight

1 Day Change

396.07%

5 Day Change

597.99%

1 Month Change

410.66%

3 Month Change

236.32%

6 Month Change

127.70%

Ytd Change

453.39%

1 Year Change

31.41%

3 Year Change

-90.82%

5 Year Change

-96.68%

10 Year Change

-96.68%

Max Change

-96.68%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment